tetano
Editor, Senior Moderator
Int J Infect Dis
. 2021 Mar 10;S1201-9712(21)00072-2.
doi: 10.1016/j.ijid.2021.01.061. Online ahead of print.
The potential significance of high avidity IgG for protective immunity towards SARS-CoV-2
Georg Bauer[SUP] 1 [/SUP]
Affiliations
Abstract
Avidity is defined as the strength of binding between IgG and its specific target epitope. IgG of high avidity is established during affinity maturation. A failure to achieve high avidity IgG may result in the lack of protective immunity towards infection and disease. It is known that the interaction between SARS-CoV-2 spike protein and its cellular receptor is driven by high affinity. Therefore it is predictable that protective antibodies towards SARS-CoV-2 should show high affinity/avidity. AVIDITY AFTER SARS-COV-2 INFECTION: Recent findings by several groups demonstrate that the serological response towards infection with SARS-CoV-2 as well as with seasonal coronaviruses is characterized by incomplete avidity maturation, followed by a decline of the serological response. This might facilitate reinfection, prevent herd immunity and potentially allow repeated cycles of infection. CONSEQUENCES FOR VACCINATION TOWARDS SARS-COV-2: Therefore, the sole focus on antibody titers reached after vaccination towards SARS-CoV-2 might not be sufficient to evaluate the degree of achieved protection. Rather, it is suggested to include avidity determination into the optimization of vaccination protocols and to try to achieve high avidity IgG directed towards SARS-CoV-2 through vaccination. Avidity determination also might be useful to control for truly protective immunity towards SARS-CoV-2 in individual cases.
Keywords: Covid-19; SARS-CoV-2; avidity; neutralizing antibody; protective immunity; vaccination.
. 2021 Mar 10;S1201-9712(21)00072-2.
doi: 10.1016/j.ijid.2021.01.061. Online ahead of print.
The potential significance of high avidity IgG for protective immunity towards SARS-CoV-2
Georg Bauer[SUP] 1 [/SUP]
Affiliations
- PMID: 33713819
- DOI: 10.1016/j.ijid.2021.01.061
Abstract
Avidity is defined as the strength of binding between IgG and its specific target epitope. IgG of high avidity is established during affinity maturation. A failure to achieve high avidity IgG may result in the lack of protective immunity towards infection and disease. It is known that the interaction between SARS-CoV-2 spike protein and its cellular receptor is driven by high affinity. Therefore it is predictable that protective antibodies towards SARS-CoV-2 should show high affinity/avidity. AVIDITY AFTER SARS-COV-2 INFECTION: Recent findings by several groups demonstrate that the serological response towards infection with SARS-CoV-2 as well as with seasonal coronaviruses is characterized by incomplete avidity maturation, followed by a decline of the serological response. This might facilitate reinfection, prevent herd immunity and potentially allow repeated cycles of infection. CONSEQUENCES FOR VACCINATION TOWARDS SARS-COV-2: Therefore, the sole focus on antibody titers reached after vaccination towards SARS-CoV-2 might not be sufficient to evaluate the degree of achieved protection. Rather, it is suggested to include avidity determination into the optimization of vaccination protocols and to try to achieve high avidity IgG directed towards SARS-CoV-2 through vaccination. Avidity determination also might be useful to control for truly protective immunity towards SARS-CoV-2 in individual cases.
Keywords: Covid-19; SARS-CoV-2; avidity; neutralizing antibody; protective immunity; vaccination.